Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Pediatric multiple sclerosis.
The Evi5 family in cellular physiology and pathology.
Twenty years of experience on stem cell transplantation in iran.
Therapeutic Advances in Pediatric Multiple Sclerosis.
MRI lesions: a surrogate for relapses in multiple sclerosis?
Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium).
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
Orthopaedic Management of Spasticity.
[Demyelinating diseases in children with acute neurological symptoms].
Micro RNA-155 participates in re-activation of encephalitogenic T cells.
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
Oral corticosteroids for multiple sclerosis relapse.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Response to IV immunoglobulin in a case of osmotic demyelination syndrome.
Guillain-Barre syndrome following dengue fever and literature review.
Multiple sclerosis: Generic glatiramer acetate - a step toward cheaper MS drugs?
Recognizing and overcoming potential barriers to oral medications for MS.
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Neurotoxocarosis alters myelin protein gene transcription and expression.
Regenerative Medicines for Remyelination: From Aspiration to Reality.
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »